Jean Boivin – Head of BlackRock Investment Institute together with Ben Powell – Chief Investment Strategist for the Middle East and APAC, Bruno Rovelli – Chief Investment Strategist for Italy, and Roelof Salomons – Chief Investment Strategist for the Netherlands and the Nordics, all forming part of the BlackRock Investment Institute share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.
Key Points
More mega forces at play : Other mega forces are driving returns beyond AI. This keeps us overweight Japanese stocks, while we favor pharmaceuticals and financials in Europe.
Market backdrop : The U.S. Supreme Court struck down the use of emergency powers to impose tariffs. The administration is already taking other measures to reimpose them.
Week ahead : Final euro area inflation data is in focus this week after the ECB held rates steady. We see policy rates on hold through 2026 if inflation slips below 2%.
Markets are laser-focused on the AI buildout, but opportunities shaped by other mega forces abound. Case in point: Japan and Europe are ramping up fiscal spending to boost self-sufficiency amid geopolitical fragmentation. Fiscal expansion is just one reason to gain exposure to this evolving trend. In Japan, sustained corporate reforms underpin our overweight to equities. In Europe, we focus on equity sectors, favoring infrastructure, pharma and financials.
International developed market stocks are outperforming this year, after walloping U.S. counterparts last year. Is it too late to jump in? We don’t think so. Japan’s return on equity (ROE) has steadily moved higher, narrowing the gap with the U.S. and Europe. See the chart. This is not just a sugar rush from fiscal expansion. It’s very much a slow-burn, structural force: A focus on capital discipline and shareholder returns is lifting underlying profitability. Japanese companies are now focused on maximizing profits, rather than minimizing debt. And a steady decline in corporate cross-shareholdings is making Japan more attractive for foreign investors. In Europe, we think overall ROEs will need to improve via productivity gains – rather than being juiced by one-off cyclical boosts. We’re focused on sectoral opportunities in the region as a result.
Japan’s corporate improvements are taking shape against a benign macro backdrop of strong nominal growth plus fiscal spending. Wages are rising, and the end of deflation has allowed companies to raise prices without losing demand. We see the historic election win for Prime Minister’s Sanae Takaichi’s Liberal Democratic Party offering continuity and predictability on this front. The LDP’s majority supports increased fiscal spending on the economy and national security. That fiscal trajectory sits within the geopolitical fragmentation mega force: it’s pushing economies toward capacity building, as nations try to become more self-sufficient. This broadening shift was on display at the recent Munich Security Conference.
Eyeing select sectors in Europe
In Europe, we like sectors that benefit from this increased spending on defense, infrastructure and energy, as we outlined in “What’s needed for Europe’s investment renaissance.” We see sectoral dispersion driving performance. Pharma is a prime example: the segment has solid earnings, low valuations relative to history and growth prospects thanks to AI innovation and a rapidly greying population. Financials are another top pick. Europeans are big savers and policymakers are making it easier for households to invest – a shift also underway in Japan via the Nippon Individual Savings Account (NISA) program – and for companies to raise capital through initiatives such as the EU’s Savings and Investment Union (SIU). We see undervalued European financials poised to channel these savings into productive investment.
The key risk: fiscal expansion does not come for free in bond markets. Investors are scrutinizing debt sustainability and demanding more compensation to hold long-duration paper as governments raise strategic spending. That shows up as higher term premia and upward pressure on long-end yields, most visibly in Japan but increasingly relevant elsewhere. Beyond this, higher issuance and stickier inflation can keep long rates elevated. That is why we stay underweight government bonds, particularly at the long end, relative to equities.
Our bottom line
Fiscal expansion tied to geopolitical fragmentation is creating return drivers outside of AI. We prefer Japanese equities over government bonds on a combo of corporate reforms and fiscal support. In Europe, we see sector dispersion driving outcomes. We focus on stimulus beneficiaries such as infrastructure, as well as pharma and financials.
Market backdrop
The Supreme Court ruled against the Trump administration’s use of emergency powers to impose tariffs, as expected. The decision doesn’t change the administration’s focus on trade as central to its economic and strategic policy, in our view. The White House quickly moved to use other measures to reimpose tariffs. The S&P 500 added 1% last week. Brent crude oil climbed about 6% to above $70 per barrel on the U.S. military buildup in the Middle East amid tensions with Iran.
We’re watching whether U.S. consumer confidence signals any change in the demand backdrop. We also look to final euro area inflation for evidence price pressures are easing after the European Central Bank held rates steady earlier this month. We expect steady growth and inflation that could drift below 2%. This should keep the ECB on hold in 2026 – a sensible choice given upward pressure on inflation from supply constraints and loosening fiscal policy.
Week Ahead
Feb. 24 : U.S. consumer confidence
Feb. 25 : Final euro area inflation
Feb. 27 : U.S. PPI
BlackRock’s Key risks & Disclaimers:
This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of 23rd February, 2026 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.
The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.
Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.
MeDirect Disclaimers:
This information has been accurately reproduced, as received from BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.
The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.
